0001209191-21-034823.txt : 20210521 0001209191-21-034823.hdr.sgml : 20210521 20210521134458 ACCESSION NUMBER: 0001209191-21-034823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210103 FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barrett Elizabeth A. CENTRAL INDEX KEY: 0001764157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38079 FILM NUMBER: 21948081 MAIL ADDRESS: STREET 1: C/O UROGEN PHARMA LTD. STREET 2: 9 HA'TA'ASIYA STREET CITY: RA'ANANA STATE: L3 ZIP: 4365007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UroGen Pharma Ltd. CENTRAL INDEX KEY: 0001668243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 BUSINESS PHONE: 972 9 770 7601 MAIL ADDRESS: STREET 1: 9 HA'TA'ASIYA ST CITY: RA'ANANA STATE: L3 ZIP: 4365007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-03 0 0001668243 UroGen Pharma Ltd. URGN 0001764157 Barrett Elizabeth A. C/O UROGEN PHARMA LTD. 400 ALEXANDER PARK PRINCETON NJ 08540 0 1 0 0 Chief Executive Officer Ordinary Shares 2021-01-03 4 M 0 8807 A 237924 D Ordinary Shares 2021-01-31 4 M 0 5000 A 242924 D Ordinary Shares 2021-05-19 4 F 0 2185 17.5089 D 240739 D Ordinary Shares 2021-05-19 4 F 0 1240 17.5089 D 239499 D Restricted Stock Units 2021-01-03 4 M 0 8807 0.00 D Ordinary Shares 8807 105689 D Restricted Stock Units 2021-01-31 4 M 0 5000 0.00 D Ordinary Shares 5000 10000 D Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. Represents shares sold to satisfy withholding tax obligations upon the settlement of RSUs. The reporting person was granted RSUs on January 3, 2019 representing 317,065 ordinary shares. 33.33% of the RSUs vested on January 3, 2020. 33.33% of the RSUs vested in equal monthly installments through January 3, 2021. The remaining 33.33% of the RSUs will vest on January 3, 2022. The reporting person was granted RSUs on January 31, 2020 representing 15,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2021. /s/ Jason Smith, Attorney-in-Fact 2021-05-20